Alteron Therapeutics

📍 Kalamazoo, United States🗓 Founded 2017👥 3 employees💰 Last funded Sep 2020
Pharmaceutical Manufacturing🌐 alterontherapeutics.com
Website LinkedIn
Alteron Therapeutics is a biotech startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death.  By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers of neurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Alteron Therapeutics?
Alteron Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Alteron Therapeutics last raise funding?
The most recent investment in Alteron Therapeutics recorded on gritt.io was in September 2020.
When was Alteron Therapeutics founded?
Alteron Therapeutics was founded in 2017.
What industry is Alteron Therapeutics in?
Alteron Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Alteron Therapeutics based?
Alteron Therapeutics is headquartered in Kalamazoo, United States.